High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana
Viruses · 2024
DOI: 10.3390/v16040592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Bonolo B Phinius und 13 weiteren Autor:innen. Beteiligte Einrichtung: Botswana Harvard Health Partnership, Private Bag BO320, Gaborone, Botswana. Hauptthemen laut MEDLINE: Hepatitis B virus, HIV Infections, Drug Resistance, Viral, Lamivudine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Gates Foundation, NIH HHS.
Abstract (Originalsprache)
(1)
Background
We aimed to determine the prevalence of hepatitis B virus (HBV) resistance-associated mutations (RAMs) in people with HBV and human immunodeficiency virus (HBV/HIV) in Botswana. (2)
Methods
We sequenced HBV deoxyribonucleic acid (DNA) from participants with HBV/HIV from the Botswana Combination Prevention Project study (2013–2018) using the Oxford Nanopore GridION platform. Consensus sequences were analyzed for genotypic and mutational profiles. (3)
Results
Overall, 98 HBV sequences had evaluable reverse transcriptase region coverage. The median participant age was 43 years (IQR: 37, 49) and 66/98 (67.4%) were female. Most participants, i.e., 86/98 (87.8%) had suppressed HIV viral load (VL). HBV RAMs were identified in 61/98 (62.2%) participants. Most RAMs were in positions 204 (60.3%), 180 (50.5%), and 173 (33.3%), mostly associated with lamivudine resistance. The triple mutations rtM204V/L180M/V173L were the most predominant (17/61 [27.9%]). Most participants (96.7%) with RAMs were on antiretroviral therapy for a median duration of 7.5 years (IQR: 4.8, 10.5). Approximately 27.9% (17/61) of participants with RAMs had undetectable HBV VL, 50.8% (31/61) had VL < 2000 IU/mL, and 13/61 (21.3%) had VL ≥ 2000 IU/mL. (4)
Conclusions
The high prevalence of lamivudine RAMs discourages the use of ART regimens with 3TC as the only HBV-active drug in people with HIV/HBV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Botswana Harvard Health Partnership, Private Bag BO320, Gaborone, Botswana.
- School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Private Bag UB 0022, Gaborone, Botswana.
- Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
- Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, Private Bag X1, Matieland 7602, South Africa.
- School of Health Systems and Public Health, University of Pretoria, Private Bag X20, Pretoria 0028, South Africa.
ORCID-Profile: Bonolo B Phinius, Motswedi Anderson, Wonderful T Choga, Sikhulile Moyo
Förderung
- FIC NIH HHS
- Gates Foundation
- NIH HHS
- NIAID NIH HHS
- Wellcome Trust
- NHGRI NIH HHS
- Bill & Melinda Gates Foundation
- Fogarty International Center at the US National Institutes of Health
Zitieren
APA
Phinius, B. B., Anderson, M., Gobe, I., Mokomane, M., Choga, W. T., Phakedi, B., Ratsoma, T., Mpebe, G., Makhema, J., Shapiro, R., Lockman, S., Musonda, R., Moyo, S., & Gaseitsiwe, S. (2024). High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana. Viruses. https://doi.org/10.3390/v16040592
Vancouver
Phinius BB, Anderson M, Gobe I, Mokomane M, Choga WT, Phakedi B, et al. High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana. Viruses. 2024. doi:10.3390/v16040592
BibTeX
@article{Phinius2024,
author = {Phinius, Bonolo B and Anderson, Motswedi and Gobe, Irene and Mokomane, Margaret and Choga, Wonderful T and Phakedi, Basetsana and Ratsoma, Tsholofelo and Mpebe, Gorata and Makhema, Joseph and Shapiro, Roger and Lockman, Shahin and Musonda, Rosemary and Moyo, Sikhulile and Gaseitsiwe, Simani},
title = {High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16040592}
}
EUVIMED